Cargando…

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells

Middle East respiratory syndrome coronavirus (MERS-CoV) presents an emerging threat to public health worldwide by causing severe respiratory disease in humans with high virulence and case fatality rate (about 35%) since 2012. Little is known about the pathogenesis and innate antiviral response in pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cong, Yu, Hart, Brit J., Gross, Robin, Zhou, Huanying, Frieman, Matthew, Bollinger, Laura, Wada, Jiro, Hensley, Lisa E., Jahrling, Peter B., Dyall, Julie, Holbrook, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864050/ https://www.ncbi.nlm.nih.gov/pubmed/29566060 http://dx.doi.org/10.1371/journal.pone.0194868

Ejemplares similares

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs
por: Postnikova, Elena, et al.
Publicado: (2018)

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies
por: Dyall, Julie, et al.
Publicado: (2017)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Licensing Natural Killers for Antiviral Immunity
por: Cronk, John M., et al.
Publicado: (2021)

Growth and Quantification of MERS‐CoV Infection
por: Coleman, Christopher M., et al.
Publicado: (2015)

Treating MERS-CoV during an outbreak
por: Coleman, Christopher M, et al.
Publicado: (2014)

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
por: Johnson, Reed F., et al.
Publicado: (2015)

Systems kinomics for characterizing host responses to high‐consequence pathogens at the NIH/NIAID Integrated Research Facility‐Frederick
por: Kindrachuk, Jason, et al.
Publicado: (2014)

Middle East respiratory syndrome: obstacles and prospects for vaccine development
por: Papaneri, Amy B, et al.
Publicado: (2015)

CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
por: Caì, Yíngyún, et al.
Publicado: (2014)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

Inflammatory Monocytes and Neutrophils Are Licensed to Kill during Memory Responses In Vivo
por: Narni-Mancinelli, Emilie, et al.
Publicado: (2011)

Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
por: Kindler, E., et al.
Publicado: (2016)

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
por: Janosko, Krisztina, et al.
Publicado: (2016)

Host Determinants of MERS-CoV Transmission and Pathogenesis
por: Widagdo, W., et al.
Publicado: (2019)

ABSL-4 Aerobiology Biosafety and Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick
por: Lackemeyer, Matthew G., et al.
Publicado: (2014)

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
por: Cong, Yu, et al.
Publicado: (2016)

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
por: Johnson, Reed F., et al.
Publicado: (2016)

Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
por: Zhao, Xu-Yun, et al.
Publicado: (2018)

Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus
por: Banerjee, Arinjay, et al.
Publicado: (2019)

The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
por: Li, Yanbai, et al.
Publicado: (2023)

Middle East respiratory syndrome coronavirus (MERS-CoV) shows poor replication and weak induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
por: Tynell, J., et al.
Publicado: (2015)

Evaluation of candidate vaccine approaches for MERS-CoV
por: Wang, Lingshu, et al.
Publicado: (2015)

Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021)

Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus
por: Kumar, Mia, et al.
Publicado: (2015)

An Updated Review of Porcine Deltacoronavirus in Terms of Prevalence, Pathogenicity, Pathogenesis and Antiviral Strategy
por: Duan, Cong
Publicado: (2022)

License to glue
por: Wells, William A.
Publicado: (2004)

Franchising & Licensing
por: SHERMAN, Andrew
Publicado: (2011)

Literature and License
Publicado: (1921)

Fraudulent Licenses
por: Nolan, C. T.
Publicado: (1916)

Liquor License
Publicado: (1858)

Liquor License
Publicado: (1876)

Teaching and Licensing
Publicado: (1880)

Inflammatory monocytes and the pathogenesis of viral encephalitis
por: Terry, Rachael L, et al.
Publicado: (2012)

A License to Practice Medicine Cannot Be a License to Harm
por: Schluger, Neil W., et al.
Publicado: (2022)

Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1
por: Wang, May Kwang-Mei, et al.
Publicado: (2018)

Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles
por: Hilligan, Kerry L., et al.
Publicado: (2020)

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2017)

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
por: Rockx, Barry, et al.
Publicado: (2020)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hdl0a8ufprcks02e9oh3gkipjs